0001144204-12-044148.txt : 20120809 0001144204-12-044148.hdr.sgml : 20120809 20120809171512 ACCESSION NUMBER: 0001144204-12-044148 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20120807 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20120809 DATE AS OF CHANGE: 20120809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MICROSEMI CORP CENTRAL INDEX KEY: 0000310568 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 952110371 STATE OF INCORPORATION: DE FISCAL YEAR END: 1002 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-08866 FILM NUMBER: 121021510 BUSINESS ADDRESS: STREET 1: ONE ENTERPRISE CITY: ALISO VIEJO STATE: CA ZIP: 92656 BUSINESS PHONE: 949-380-6100 MAIL ADDRESS: STREET 1: ONE ENTERPRISE CITY: ALISO VIEJO STATE: CA ZIP: 92656 FORMER COMPANY: FORMER CONFORMED NAME: MICROSEMICONDUCTOR CORP DATE OF NAME CHANGE: 19830323 8-K 1 v320894_8k.htm CURRENT REPORT
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

 

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported):  August 7, 2012

 

 

Microsemi Corporation

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware   000-08866   95-2110371

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

One Enterprise

Aliso Viejo, California

  92656
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (949) 380-6100

 

 

(Former Name or Former Address, if Changed Since Last Report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 
 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On August 7, 2012, Microsemi Corporation (the “Company”) appointed James V. Mazzo to its Board of Directors (the “Board”). Concurrent with his appointment as a director, Mr. Mazzo was appointed to the Governance and Nominating Committee and the Compensation Committee of the Board of Directors. There are no arrangements or understandings between Mr. Mazzo and any other person pursuant to which Mr. Mazzo was appointed to serve on the Board of Directors. Mr. Mazzo has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

 

Mr. Mazzo will receive compensation for his services as a director in accordance with the Company’s standard compensation program for non-employee directors, which is summarized in Exhibit 10.14 to the Company’s Annual Report on Form 10-K for its fiscal year ended October 3, 2010, as filed with the Securities and Exchange Commission (“SEC”) on November 23, 2010.

 

In connection with the appointment, the Company will enter into an indemnification agreement with Mr. Mazzo, the terms of which are identical in all material respects to the form of indemnification agreement that the Company has previously entered into with each of its directors, which was filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K as filed with the SEC on September 3, 2008.

 

Item 7.01 Regulation FD Disclosure

 

The Company issued a press release on August 9, 2012, announcing the appointment of Mr. Mazzo to the Board of Directors. The press release making this announcement is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.


Item 9.01 Financial Statements and Exhibits

 

Exhibit    
Number   Description
     
99.1   Text of press release issued by the Company on August 9, 2012.

 

 

 
 

SIGNATURE

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  Microsemi Corporation
(Registrant)
   
      Date: August 9, 2012 By:  /s/ John W. Hohener
    John W. Hohener
Executive Vice President, Chief Financial Officer,
Treasurer and Secretary

 

 
 

EXHIBIT INDEX

 

Exhibit    
Number   Description
     
99.1   Text of press release issued by the Company on August 9, 2012.

 

 

 
 

EX-99.1 2 v320894_ex99-1.htm EXHIBIT 99.1

Microsemi Appoints New Board Member

ALISO VIEJO, Calif., Aug. 9, 2012 /PRNewswire/ -- Microsemi Corporation (Nasdaq: MSCC), a leading provider of semiconductor solutions differentiated by power, security, reliability and performance, today announced the appointment of James V. Mazzo to its board of directors.

(Logo: http://photos.prnewswire.com/prnh/20110909/MM66070LOGO)

Mazzo currently serves as senior vice president, Abbott Medical Optics. Abbott is a global leader in advanced refractive technologies for eye care professionals and patients. Headquartered in Santa Ana, Calif., AMO offers market-leading technologies and services designed to address vision disorders at all stages of life. He led the company through a 2002 spin-off from Allergan Inc., and its 2009 sale to Abbott.

Prior to leading AMO, Mazzo progressed throughout a 22-year career at Allergan, where he held a variety of senior executive-level positions. He spent approximately 12 years working outside the United States, serving as president of Allergan's Europe/Africa/Middle East region, vice president and managing director in Italy, and director of marketing in Canada.

Mazzo lends his expertise to a number of nonprofit organizations, associations and higher education institutions, including: Foundation of the American Academy of Ophthalmology; International Intraocular Implant Club; OCTANe board of directors; Chapman University board of trustees; University of San Diego board of trustees; and the University of California, Irvine Dean's board of directors' Executive Committee and Dean's Board of Business and Engineering. He also recently completed a term as chairman of AdvaMed and is a former member of the Beckman Coulter board of directors.

Microsemi and the Microsemi logo are registered trademarks or service marks of Microsemi Corporation and/or its affiliates. Third-party trademarks and service marks mentioned herein are the property of their respective owners.



CONTACT: Beth P. Quezada, Communications Specialist, +1-949-380-6100, press@microsemi.com